Scientific Session
Scleroderma, Scleroderma Mimics, and Mixed Connective Tissue Disease (MCTD)
John Pauling, PhD, BSc, FRCP, MBBCH
North Bristol NHS Trust
Bristol, United Kingdom
Disclosure(s): AstraZeneca: Consultant (Ongoing); Boehringer-Ingelheim: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Johnson & Johnson: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)